BioLife Solutions, Inc. (BLFS) Hit a 52 Week High, Can the Run Continue?

Company Performance - BioLife Solutions, Inc. (BLFS) shares have increased by 9.8% over the past month and have reached a new 52-week high of $29.46 [1] - Year-to-date, the stock has gained 9.8%, outperforming the Zacks Medical sector, which has seen a decline of 0.6%, and the Zacks Medical - Products industry, which has returned 20.9% [1] Earnings and Valuation - The company has a strong record of positive earnings surprises, having beaten earnings consensus estimates in the last four quarters [2] - In the latest earnings report on November 12, 2024, BioLife Solutions reported an EPS of $-0.02, surpassing the consensus estimate of $-0.09, and beat the revenue estimate by 21.98% [2] Valuation Metrics - BioLife Solutions has a Value Score of F, while its Growth and Momentum Scores are A and B, respectively, resulting in a VGM Score of B [5] - The Zacks Rank for BioLife Solutions is 2 (Buy), indicating rising earnings estimates and suggesting potential for the stock in the near future [6] Industry Comparison - The Medical - Products industry is positioned in the top 35% of all industries, indicating favorable conditions for both BioLife Solutions and its peer, Phibro Animal Health Corporation (PAHC) [9] - PAHC has a Zacks Rank of 2 (Buy) with strong earnings performance, having beaten consensus estimates by 52.17% in the last quarter [8]